African & Global infection
Understanding SARS-CoV-2 infection across Africa and globally
Enhance surveillance capacity in Africa
CVR researchers are part of AFRICO19, a collaborative project designed to enhance our capacity to understand SARS-CoV-2 infection in Kenya, The Gambia, and Uganda.
CVR researchers will provide genomics and bioinformatics support.
AFRICO19 is a partnership project with colleagues at the MRC/UVRI and LSHTM Uganda Research Unit, KEMRI-Wellcome Trust Research Programme, London School of Hygiene and Tropical Medicine and University of Glasgow, funded by Wellcome.
The CVR has also secured funding from the University of Glasgow to support two new projects focusing on COVID-19 related activities in low- and middle-income countries:
- CVR researchers will collaborate with colleagues at the MRC/UVRI and LSHTM Uganda Research Unit and Uganda Virus Research Institute to support the establishment of a biorepository of sera. Samples will be obtained from confirmed cases of COVID-19 and community control groups in Uganda. This biorepository will be essential for testing immunoassays for detecting COVID-19 infections and for determining if a protective immune response occurs in recovered COVID-19 patients.
- CVR researchers will collaborate with colleagues at the University of Malawi’s College of Medicine and Glasgow’s College of Science & Engineering to compare point-of-care (POC) diagnostics to the existing gold standard RT-PCR tests. While also evaluating the at-risk Malawian health care worker population for COVID-19 exposure. This will provide guidance on diagnostics and an understanding of exposure risks for health care workers.